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Background: Heart transplantation is being done at Frontier Life-
line Hospital & DR. K.M. Cherian Heart Foundation, Chennai since
2004. So far 41 heart transplants have taken place till date.
Methods and Results: A vast majority 80% of the transplant re-
cipients were male. A majority i.e 46% of the transplant recipients
were in the age group of 41 e 60 yrs and 36% of the transplant
recipients are in the age group of 21 e 40 yrs and 17% were in the
age group 0 -20 yrs old.
The major cause for cardiac transplantation is Dilated Cardio-
myopathy in 65% of the patients, Ischemic Cardiomyopathy in
17% and the rest were diagnosed as Restrictive Cardiomyopathy,
Hypertrophic Cardiomyopathy and Cardiac Tumor.
A vast majority 85% of the transplant recipient hearts were
taken from the hospitals in Chennai through ambulance (road)
and the remaining 15% of the hearts were taken from outside
Chennai through flight& ambulance (Vellore, Madurai, Bangalore,
Coimbatore).
Majority of the transplant surgeries were done by Bicaval tech-
nique. Immunosuppressant protocol started with induction in 50%
of patients. Immunosuppressants used were cyclosporine 70%,
tacrolimus 30%, mycophenolate 100% and prednisolone 100%.
No endomyocardial biopsy was done, evaluation of rejection is
done by ECHO criteria only. The causes of death among post
transplant patients were mostly infections, especially fungal in
90%, late rejection occurred 50% of transplant patients, early renal
failure in 70%, Anemia in 10%, complete heart block in 1% and
infection of urinary tract in 10% of patients.
Conclusion: Heart transplantation is here to stay. After changes in
our strategies of induction therapy and modification of immu-
nosuppression, our survival rates have improved.
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Background: Frontier Lifeline Hospital & DR. K.M. Cherian Heart
Foundation, Chennai has done maximum number of Heart
Transplants in India to our knowledge. The study reviews the
static and dynamic ECG changes seen in 41 heart transplantation
patients done in our center.
Methods & Results: ECG changes post transplantation can be
divided into two groups.
Fixed ECG changes which persists with the patients all through
his life. These fixed ECG changes appeared first time after heart
transplantation. These changes were right bundle branch block in
26% of patients, left bundle branch block in 10.52% & Sinus
tachycardia 5.26%, right axis deviation in 10.52%, left axis devia-
tion in 5.26%, poor R wave progression in 18.4%, Prolonged PR
interval 5.26%.
Dynamic ECG changes occurring anytime during post heart
transplantation which were of benign prognosis. There were
VPC’s especially VPC’s with LBBB morphology. LAE occurred
usually after 1 year of heart transplantation in 18% patients.
ECG changes major prognostic implication were junctional
tachycardia 2%, prolonged PR interval 8%, prolonged QTC interval
4%, decreased in QRS amplitude of ECG’s which portended a bad
prognosis 20%. Subsequent in size of QRS amplitude meant a
better prognosis. This is perhaps the largest number presented to
our knowledge with Indian patients.
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Background: Dilated cardiomyopathy (DCM) is a common clinical
cardiology problem. Still, there is no uniform definition for this
entity. One popular definition for DCM is based on following pa-
rameters (1)LVEF  45% (2) fractional shortening  25% and (3)
LVEDD  112 % predicted value corrected for age and body surface
area. By tradition we use EDD to define LV dilatation but hemo-
dynamic principles would suggest LV ESD may be ideal to define
DCM as it is less dependent on preload. Further if MR is associated
it can confound LVEDD.
Methods: In this context, we analysed the relationship between
LV ESD, EDD, EF% and the impact of treatment on these parame-
ters. 25 patients with DCM who were attending our OPD were the
subjects of the study.
Table. Documentation of HF medications use from any outpatient encounter in patients with EF ≤40% by various
subgroups.
Medications
(any use)
Men
[N¼ 1225]
Women
[N¼ 3679]
<65 years
[N¼ 11874]
65 years
[N¼ 3949]
Receiving care in
a practice with
EMR [N¼15726]
Receiving care in
practice without
EMR [N¼214]
History of MI
[N¼ 2758]
No history of
MI [N¼ 13182]
ACE-I or ARB
n, (%)
4232(34.5) 1025(27.9) 3804(32.0) 1418(35.9) 5197(33.1) 60 (28.0) 1408(51.1) 3849 (29.2)
Beta blockers
n, (%)
4381(35.7) 1069(29.1) 3949(33.3) 1486(37.6) 5407(34.4) 43 (20.1) 1454(52.7) 3996 (30.3)
ACE-I/ARB and
beta blocker
n, (%)
3768(30.7) 879(23.9) 3366(28.4) 1273 (32.2) 4630(29.4) 17 (7.9) 1342 (48.7) 3305 (25.1)
ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker, EF: ejection fraction, EMR: electronic medical record, HF:
heart failure, MI: myocardial infarction
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